Robert Lasser | Psychiatrist.com

Original Research

A Randomized Controlled Trial of the Efficacy and Safety of Lisdexamfetamine Dimesylate as Augmentation Therapy in Adults With Residual Symptoms of Major Depressive Disorder After Treatment With Escitalopram

Effect of Zuranolone on Anxiety and Insomnia in Postpartum Depression

Original Research

Effect of Zuranolone on Anxiety and Insomnia in Postpartum Depression

Zuranolone was associated with improvements in depressive and anxiety symptoms and was beneficial for insomnia and patient-perceived functional health in patients with PPD.

Effect of Zuranolone vs Placebo in MDD

Original Research

Effect of Zuranolone vs Placebo in MDD

This phase 3 RCT found significant improvement in depressive symptoms with zuranolone beginning at day 3 of treatment.

Long-Term Safety and Efficacy of Zuranolone in MDD

Original Research

Long-Term Safety and Efficacy of Zuranolone in MDD

Most patients with MDD achieved response after 14 days of zuranolone treatment. For patients who responded to their first treatment, the time to repeat treatment was over 4 months.